-

$undefined

N/A

(N/A)

Quince Therapeutics :QNCX

Location: | Industry: | Sector:


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

29.21M

Cash

47.85M

Avg Qtr Burn

-7.608M

Short % of Float

7.56%

Insider Ownership

13.52%

Institutional Own.

22.91%

Qtr Updated

09/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
EryDex Details
Rare genetic disease, Neurological disorder, Ataxia Telangiectasia

Phase 3

Data readout

Atuzaginstat (COR388) / Lysine gingipain inhibitor Details
Alzheimer's disease, Neurological disorder

Failed

Discontinued

COR588 (Lysine gingipain inhibitor) Details
Mental health, Alzheimer's disease, Neurological disorder

Failed

Discontinued

Failed

Discontinued

Failed

Discontinued